In the past, several genetic factors have been found to correlate with unfavorable outcome in neuroblastoma, including loss of heterozygosity at chromosomes 1p [8], trisomy of 17q [9] and the amplification of the N-myc proto-oncogene protein (MYCN) [10]. The gene discussed is MYCN; the disease is neuroblastoma.